{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T03:49:32Z","timestamp":1790480972807,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T00:00:00Z","timestamp":1595289600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T00:00:00Z","timestamp":1595289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK097605"],"award-info":[{"award-number":["DK097605"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK097605"],"award-info":[{"award-number":["DK097605"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["EY027731"],"award-info":[{"award-number":["EY027731"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Recent advances in genetic analyses have significantly refined human type 1 diabetes (T1D) associated loci. The goal of such effort is to identify the causal genes and have a complete understanding of the molecular pathways that independently or interactively influence cellular processes leading to the destruction of insulin producing pancreatic \u03b2 cells. <jats:italic>UBASH3A<\/jats:italic> has been suggested as the underlying gene for a human T1D associated region on chromosome 21. To further evaluate the role of UBASH3A in T1D, we targeted <jats:italic>Ubash3a<\/jats:italic> in NOD mice using zinc-finger nuclease mediated mutagenesis. In both 10-week-old females and males, significantly more advanced insulitis was observed in UBASH3A-deficient than in wild-type NOD mice. Consistently, UBASH3A-deficient NOD mice developed accelerated T1D in both sexes, which was associated with increased accumulation of \u03b2-cell autoreactive T cells in the spleen and pancreatic lymph node. Adoptive transfer of splenic T cells into NOD.<jats:italic>Rag1<\/jats:italic><jats:sup><jats:italic>-\/-<\/jats:italic><\/jats:sup> mice demonstrated that UBASH3A deficiency in T cells was sufficient to promote T1D development. Our results provide strong evidence to further support a role of UBASH3A in T1D. In addition to T1D, UBASH3A deficiency also promoted salivary gland inflammation in females, demonstrating its broad impact on autoimmunity.<\/jats:p>","DOI":"10.1038\/s41598-020-68956-6","type":"journal-article","created":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T10:02:52Z","timestamp":1595325772000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["UBASH3A deficiency accelerates type 1 diabetes development and enhances salivary gland inflammation in NOD mice"],"prefix":"10.1038","volume":"10","author":[{"given":"Yi-Guang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley E.","family":"Ciecko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamim","family":"Khaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Grzybowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aron M.","family":"Geurts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott M.","family":"Lieberman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,21]]},"reference":[{"key":"68956_CR1","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1016\/S0140-6736(16)30582-7","volume":"387","author":"F Pociot","year":"2016","unstructured":"Pociot, F. & Lernmark, A. Genetic risk factors for type 1 diabetes. Lancet 387, 2331\u20132339 (2016).","journal-title":"Lancet"},{"key":"68956_CR2","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/ng.381","volume":"41","author":"JC Barrett","year":"2009","unstructured":"Barrett, J. C. et al. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat. Genet. 41, 703\u2013707 (2009).","journal-title":"Nat. Genet."},{"key":"68956_CR3","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/ng.3245","volume":"47","author":"S Onengut-Gumuscu","year":"2015","unstructured":"Onengut-Gumuscu, S. et al. Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers. Nat. Genet. 47, 381\u2013386 (2015).","journal-title":"Nat. Genet."},{"key":"68956_CR4","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.2337\/db16-1023","volume":"66","author":"Y Ge","year":"2017","unstructured":"Ge, Y., Paisie, T. K., Newman, J. R. B., McIntyre, L. M. & Concannon, P. UBASH3A mediates risk for type 1 diabetes through inhibition of T-cell receptor-induced NF-kappaB signaling. Diabetes 66, 2033\u20132043 (2017).","journal-title":"Diabetes"},{"key":"68956_CR5","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1038\/s41431-018-0123-5","volume":"26","author":"Y Ge","year":"2018","unstructured":"Ge, Y. & Concannon, P. Molecular-genetic characterization of common, noncoding UBASH3A variants associated with type 1 diabetes. Eur. J. Hum. Genet. 26, 1060\u20131064 (2018).","journal-title":"Eur. J. Hum. Genet."},{"key":"68956_CR6","doi-asserted-by":"publisher","first-page":"109424","DOI":"10.1016\/j.cellsig.2019.109424","volume":"65","author":"AY Tsygankov","year":"2020","unstructured":"Tsygankov, A. Y. TULA proteins as signaling regulators. Cell Signal 65, 109424 (2020).","journal-title":"Cell Signal"},{"key":"68956_CR7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S1074-7613(03)00351-0","volume":"20","author":"N Carpino","year":"2004","unstructured":"Carpino, N. et al. Regulation of ZAP-70 activation and TCR signaling by two related proteins, Sts-1 and Sts-2. Immunity 20, 37\u201346 (2004).","journal-title":"Immunity"},{"key":"68956_CR8","doi-asserted-by":"publisher","first-page":"7491","DOI":"10.1128\/MCB.22.21.7491-7500.2002","volume":"22","author":"N Carpino","year":"2002","unstructured":"Carpino, N. et al. Identification, cDNA cloning, and targeted deletion of p70, a novel, ubiquitously expressed SH3 domain-containing protein. Mol. Cell Biol. 22, 7491\u20137500 (2002).","journal-title":"Mol. Cell Biol."},{"key":"68956_CR9","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/icb.2014.60","volume":"92","author":"TN Newman","year":"2014","unstructured":"Newman, T. N. et al. Members of the novel UBASH3\/STS\/TULA family of cellular regulators suppress T-cell-driven inflammatory responses in vivo. Immunol. Cell Biol. 92, 837\u2013850 (2014).","journal-title":"Immunol. Cell Biol."},{"key":"68956_CR10","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.molcel.2007.06.015","volume":"27","author":"A Mikhailik","year":"2007","unstructured":"Mikhailik, A. et al. A phosphatase activity of Sts-1 contributes to the suppression of TCR signaling. Mol. Cell 27, 486\u2013497 (2007).","journal-title":"Mol. Cell"},{"key":"68956_CR11","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1002\/jcb.21678","volume":"104","author":"R Agrawal","year":"2008","unstructured":"Agrawal, R., Carpino, N. & Tsygankov, A. TULA proteins regulate activity of the protein tyrosine kinase Syk. J. Cell. Biochem. 104, 953\u2013964 (2008).","journal-title":"J. Cell. Biochem."},{"key":"68956_CR12","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.4049\/jimmunol.1801338","volume":"203","author":"Y Ge","year":"2019","unstructured":"Ge, Y., Paisie, T. K., Chen, S. & Concannon, P. UBASH3A regulates the synthesis and dynamics of TCR-CD3 complexes. J. Immunol. 203, 2827\u20132836 (2019).","journal-title":"J. Immunol."},{"key":"68956_CR13","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s00281-010-0204-1","volume":"33","author":"JP Driver","year":"2011","unstructured":"Driver, J. P., Serreze, D. V. & Chen, Y. G. Mouse models for the study of autoimmune type 1 diabetes: a NOD to similarities and differences to human disease. Semin. Immunopathol. 33, 67\u201387 (2011).","journal-title":"Semin. Immunopathol."},{"key":"68956_CR14","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3389\/fendo.2018.00051","volume":"9","author":"YG Chen","year":"2018","unstructured":"Chen, Y. G., Mathews, C. E. & Driver, J. P. The Role of NOD Mice in Type 1 Diabetes Research: Lessons from the Past and Recommendations for the Future. Front Endocrinol. (Lausanne) 9, 51 (2018).","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"68956_CR15","doi-asserted-by":"publisher","first-page":"68","DOI":"10.2337\/db13-0192","volume":"63","author":"YG Chen","year":"2014","unstructured":"Chen, Y. G. et al. Gene targeting in NOD mouse embryos using zinc-finger nucleases. Diabetes 63, 68\u201374 (2014).","journal-title":"Diabetes"},{"key":"68956_CR16","doi-asserted-by":"publisher","first-page":"6675","DOI":"10.4049\/jimmunol.177.10.6675","volume":"177","author":"DV Serreze","year":"2006","unstructured":"Serreze, D. V. et al. Partial versus full allogeneic hemopoietic chimerization is a preferential means to inhibit type 1 diabetes as the latter induces generalized immunosuppression. J. Immunol. 177, 6675\u20136684 (2006).","journal-title":"J. Immunol."},{"key":"68956_CR17","doi-asserted-by":"publisher","first-page":"4278","DOI":"10.4049\/jimmunol.1003733","volume":"186","author":"YG Chen","year":"2011","unstructured":"Chen, Y. G. et al. Testing the role of P2X7 receptors in the development of type 1 diabetes in nonobese diabetic mice. J. Immunol. 186, 4278\u20134284 (2011).","journal-title":"J. Immunol."},{"key":"68956_CR18","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/gene.2014.81","volume":"16","author":"SW Tsaih","year":"2015","unstructured":"Tsaih, S. W. et al. A locus on mouse chromosome 13 inversely regulates CD1d expression and the development of invariant natural killer T-cells. Genes Immun. 16, 221\u2013230 (2015).","journal-title":"Genes Immun."},{"key":"68956_CR19","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/icb.2017.38","volume":"95","author":"JY Barr","year":"2017","unstructured":"Barr, J. Y., Wang, X., Meyerholz, D. K. & Lieberman, S. M. CD8 T cells contribute to lacrimal gland pathology in the nonobese diabetic mouse model of Sjogren syndrome. Immunol. Cell Biol. 95, 684\u2013694 (2017).","journal-title":"Immunol. Cell Biol."},{"key":"68956_CR20","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671\u2013675 (2012).","journal-title":"Nat. Methods"},{"key":"68956_CR21","doi-asserted-by":"publisher","first-page":"3073","DOI":"10.1016\/j.celrep.2019.11.010","volume":"29","author":"AE Ciecko","year":"2019","unstructured":"Ciecko, A. E. et al. Interleukin-27 is essential for type 1 diabetes development and sjogren syndrome-like inflammation. Cell. Rep. 29, 3073\u20133086 (2019).","journal-title":"Cell. Rep."},{"key":"68956_CR22","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.2174\/1381612821666150316120024","volume":"21","author":"YS Park","year":"2015","unstructured":"Park, Y. S., Gauna, A. E. & Cha, S. Mouse models of primary Sjogren\u2019s syndrome. Curr. Pharm. Des. 21, 2350\u20132364 (2015).","journal-title":"Curr. Pharm. Des."},{"key":"68956_CR23","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1172\/JCI1230","volume":"101","author":"RE Hunger","year":"1998","unstructured":"Hunger, R. E., Carnaud, C., Vogt, I. & Mueller, C. Male gonadal environment paradoxically promotes dacryoadenitis in nonobese diabetic mice. J. Clin. Investig. 101, 1300\u20131309 (1998).","journal-title":"J. Clin. Investig."},{"key":"68956_CR24","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1172\/JCI118879","volume":"98","author":"RE Hunger","year":"1996","unstructured":"Hunger, R. E. et al. Inhibition of submandibular and lacrimal gland infiltration in nonobese diabetic mice by transgenic expression of soluble TNF-receptor p55. J. Clin. Investig. 98, 954\u2013961 (1996).","journal-title":"J. Clin. Investig."},{"key":"68956_CR25","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/imm.12439","volume":"145","author":"SM Lieberman","year":"2015","unstructured":"Lieberman, S. M., Kreiger, P. A. & Koretzky, G. A. Reversible lacrimal gland-protective regulatory T cell dysfunction underlies male-specific autoimmune dacryoadenitis in the nonobese diabetic mouse model of Sjogren syndrome. Immunology 145, 232 (2015).","journal-title":"Immunology"},{"key":"68956_CR26","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S0002-9440(10)61738-5","volume":"159","author":"A Mikulowska-Mennis","year":"2001","unstructured":"Mikulowska-Mennis, A., Xu, B., Berberian, J. M. & Michie, S. A. Lymphocyte migration to inflamed lacrimal glands is mediated by vascular cell adhesion molecule-1\/alpha(4)beta(1) integrin, peripheral node addressin\/l-selectin, and lymphocyte function-associated antigen-1 adhesion pathways. Am. J. Pathol. 159, 671\u2013681 (2001).","journal-title":"Am. J. Pathol."},{"key":"68956_CR27","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1046\/j.1365-2249.1997.4691368.x","volume":"109","author":"M Takahashi","year":"1997","unstructured":"Takahashi, M. et al. High incidence of autoimmune dacryoadenitis in male non-obese diabetic (NOD) mice depending on sex steroid. Clin. Exp. Immunol. 109, 555\u2013561 (1997).","journal-title":"Clin. Exp. Immunol."},{"key":"68956_CR28","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1006\/exer.1999.0715","volume":"69","author":"I Toda","year":"1999","unstructured":"Toda, I. et al. Impact of gender on exocrine gland inflammation in mouse models of Sjogren\u2019s syndrome. Exp. Eye Res. 69, 355\u2013366 (1999).","journal-title":"Exp. Eye Res."},{"key":"68956_CR29","doi-asserted-by":"publisher","first-page":"e1002004","DOI":"10.1371\/journal.pgen.1002004","volume":"7","author":"A Zhernakova","year":"2011","unstructured":"Zhernakova, A. et al. Meta-analysis of genome-wide association studies in celiac disease and rheumatoid arthritis identifies fourteen non-HLA shared loci. PLoS Genet 7, e1002004 (2011).","journal-title":"PLoS Genet"},{"key":"68956_CR30","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/ng.3745","volume":"49","author":"SG Ji","year":"2017","unstructured":"Ji, S. G. et al. Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease. Nat Genet 49, 269\u2013273 (2017).","journal-title":"Nat Genet"},{"key":"68956_CR31","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/gene.2017.15","volume":"18","author":"Y Li","year":"2017","unstructured":"Li, Y. et al. Association of UBASH3A gene polymorphism and atopic dermatitis in the Chinese Han population. Genes Immun. 18, 158\u2013162 (2017).","journal-title":"Genes Immun."},{"key":"68956_CR32","doi-asserted-by":"publisher","first-page":"15943","DOI":"10.1074\/jbc.M110.177634","volume":"286","author":"B San Luis","year":"2011","unstructured":"San Luis, B., Sondgeroth, B., Nassar, N. & Carpino, N. Sts-2 is a phosphatase that negatively regulates zeta-associated protein (ZAP)-70 and T cell receptor signaling pathways. J. Biol. Chem. 286, 15943\u201315954 (2011).","journal-title":"J. Biol. Chem."},{"key":"68956_CR33","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1084\/jem.20151426","volume":"213","author":"H Hu","year":"2016","unstructured":"Hu, H. et al. Otud7b facilitates T cell activation and inflammatory responses by regulating Zap70 ubiquitination. J. Exp. Med. 213, 399\u2013414 (2016).","journal-title":"J. Exp. Med."},{"key":"68956_CR34","doi-asserted-by":"publisher","first-page":"4373","DOI":"10.1126\/scisignal.aav4373","volume":"12","author":"MS Kong","year":"2019","unstructured":"Kong, M. S. et al. Inhibition of T cell activation and function by the adaptor protein CIN85. Sci. Signal 12, 4373 (2019).","journal-title":"Sci. Signal"},{"key":"68956_CR35","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1021\/bi802219n","volume":"48","author":"Y Chen","year":"2009","unstructured":"Chen, Y., Jakoncic, J., Carpino, N. & Nassar, N. Structural and functional characterization of the 2H-phosphatase domain of Sts-2 reveals an acid-dependent phosphatase activity. Biochemistry 48, 1681\u20131690 (2009).","journal-title":"Biochemistry"},{"key":"68956_CR36","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1182\/blood-2010-02-268136","volume":"116","author":"DH Thomas","year":"2010","unstructured":"Thomas, D. H. et al. A novel histidine tyrosine phosphatase, TULA-2, associates with Syk and negatively regulates GPVI signaling in platelets. Blood 116, 2570\u20132578 (2010).","journal-title":"Blood"},{"key":"68956_CR37","doi-asserted-by":"publisher","first-page":"876","DOI":"10.15252\/msb.20166837","volume":"12","author":"G Voisinne","year":"2016","unstructured":"Voisinne, G. et al. Co-recruitment analysis of the CBL and CBLB signalosomes in primary T cells identifies CD5 as a key regulator of TCR-induced ubiquitylation. Mol. Syst. Biol. 12, 876 (2016).","journal-title":"Mol. Syst. Biol."},{"key":"68956_CR38","doi-asserted-by":"publisher","first-page":"30920","DOI":"10.1074\/jbc.M706870200","volume":"282","author":"TS Collingwood","year":"2007","unstructured":"Collingwood, T. S. et al. T-cell ubiquitin ligand affects cell death through a functional interaction with apoptosis-inducing factor, a key factor of caspase-independent apoptosis. J. Biol. Chem. 282, 30920\u201330928 (2007).","journal-title":"J. Biol. Chem."},{"key":"68956_CR39","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/ng1958","volume":"39","author":"J Yamanouchi","year":"2007","unstructured":"Yamanouchi, J. et al. Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity. Nat. Genet. 39, 329\u2013337 (2007).","journal-title":"Nat. Genet."},{"key":"68956_CR40","doi-asserted-by":"publisher","first-page":"3166","DOI":"10.4049\/jimmunol.1900848","volume":"203","author":"W Anderson","year":"2019","unstructured":"Anderson, W., Thorpe, J., Long, S. A. & Rawlings, D. J. Efficient CRISPR\/Cas9 disruption of autoimmune-associated genes reveals key signaling programs in primary human T cells. J. Immunol. 203, 3166\u20133178 (2019).","journal-title":"J. Immunol."},{"key":"68956_CR41","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.3390\/ijms19103259","volume":"19","author":"Y Chaly","year":"2018","unstructured":"Chaly, Y. et al. Type I interferon signaling is required for dacryoadenitis in the nonobese diabetic mouse model of Sjogren syndrome. Int. J. Mol. Sci. 19, 3259 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"68956_CR42","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1111\/j.0300-9475.2004.01508.x","volume":"60","author":"S Cha","year":"2004","unstructured":"Cha, S. et al. A dual role for interferon-gamma in the pathogenesis of Sjogren\u2019s syndrome-like autoimmune exocrinopathy in the nonobese diabetic mouse. Scand. J. Immunol. 60, 552\u2013565 (2004).","journal-title":"Scand. J. Immunol."},{"key":"68956_CR43","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.2337\/db18-0331","volume":"67","author":"JA Carrero","year":"2018","unstructured":"Carrero, J. A., Benshoff, N. D., Nalley, K. & Unanue, E. R. Type I and II interferon receptors differentially regulate Type 1 diabetes susceptibility in male versus female NOD mice. Diabetes 67, 1830\u20131835 (2018).","journal-title":"Diabetes"},{"key":"68956_CR44","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/imm.12439","volume":"145","author":"SM Lieberman","year":"2015","unstructured":"Lieberman, S. M., Kreiger, P. A. & Koretzky, G. A. Reversible lacrimal gland-protective regulatory T-cell dysfunction underlies male-specific autoimmune dacryoadenitis in the non-obese diabetic mouse model of Sjogren syndrome. Immunology 145, 232\u2013241 (2015).","journal-title":"Immunology"},{"key":"68956_CR45","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/imm.12948","volume":"155","author":"JY Barr","year":"2018","unstructured":"Barr, J. Y., Wang, X., Kreiger, P. A. & Lieberman, S. M. Salivary-gland-protective regulatory T-cell dysfunction underlies female-specific sialadenitis in the non-obese diabetic mouse model of Sjogren syndrome. Immunology 155, 225\u2013237 (2018).","journal-title":"Immunology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-68956-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-68956-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-68956-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T14:00:28Z","timestamp":1670335228000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-68956-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,21]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["68956"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-68956-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,21]]},"assertion":[{"value":"16 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12019"}}